May 20, 2024

non-small cell lung cancer

RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Lung Cancer Treatment with RYBREVANT
3 min read

RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Johnson & Johnson (NYSE: JNJ) announced today that following a priority review, the U.S. Food and Drug Administration...
Read More

You may have missed

IMA to Organize Conference on “Multispecialities Cardio Reno Metabolic & HF in Women” Tomorrow Multispecialities Cardio Reno Metabolic Conference & HF in Women
3 min read

IMA to Organize Conference on “Multispecialities Cardio Reno Metabolic & HF in Women” Tomorrow

May 18, 2024
Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires Justrite Lithium-Ion Battery Charging Cabinet
2 min read

Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires

May 18, 2024
Bot Image, Inc. introduced its Prostate Cancer detection, diagnosis, and screening software at urologist meeting in San Antonio, Texas Prostate Cancer Detection Software ProstatID
2 min read

Bot Image, Inc. introduced its Prostate Cancer detection, diagnosis, and screening software at urologist meeting in San Antonio, Texas

May 18, 2024
WS Audiology Strengthens Commitment to Innovation with New R&D Centre of Excellence in Hyderabad WS Audiology R&D Centre of Excellence in Hyderabad
2 min read

WS Audiology Strengthens Commitment to Innovation with New R&D Centre of Excellence in Hyderabad

May 18, 2024